NVDA vs TMO: Which Is the Better Buy?
Side-by-side comparison of NVIDIA Corporation and Thermo Fisher Scientific Inc. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
NVIDIA Corporation · Technology
$182.08
+59.3% upside to fair value
High Conviction
Grade A-
VS
Thermo Fisher Scientific Inc. · Healthcare
$462.60
+10.1% upside to fair value
Grade B
QuantHub Verdict
NVDA has more upside to fair value
(+59.3%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
NVDA |
TMO |
| Current Price |
$182.08 |
$462.60 |
| Fair Value Estimate |
$290.00 |
$509.20 |
| Upside to Fair Value |
+59.3%
|
+10.1%
|
| Market Cap |
$4,425.5B |
$171.9B |
| Forward P/E |
—
|
25.1x
|
| EV / EBITDA |
31.4x
|
19.0x
|
| Price / Sales |
21.0x
|
3.8x
|
| Price / FCF |
46.9x
|
25.5x
|
| Revenue Growth YoY |
+65.5%
|
+6.2%
|
| Gross Margin |
71.1%
|
39.4%
|
| Operating Margin |
60.4%
|
17.8%
|
| Return on Equity |
76.3%
|
13.3%
|
| Dividend Yield |
0.02% |
0% |
| FCF Yield |
2.13%
|
3.92%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
NVIDIA is the foundational infrastructure layer of the AI era. Data Center revenue reached $193.7B in FY2026, up 66% YoY, powered by insatiable demand for Blackwell B200 GPUs across hyperscalers and sovereign AI programs. The company generates $96.7B in annual free cash flow with 71% gross margins and 56% net margins, making it the most profitable semiconductor business in history. At P/E 37.7x v…
Thermo Fisher Scientific Inc. operates in the healthcare sector, specializing in medical diagnostics and research tools across four main segments: Laboratory Products and Biopharma Services, Life Sciences Solutions, Analytical Instruments, and Specialty Diagnostics. The company demonstrates medium business quality with steady revenue growth of 6.2% and earnings growth of 9.6% in the most recent q…
Accumulation Zones
| Metric |
NVDA |
TMO |
| Zone Low |
$218.00 |
$381.90 |
| Zone High |
$250.00 |
$432.82 |
| In Buy Zone? |
Yes
|
No
|